Cary Claiborne

Cary J.
Claiborne was the founder of Prosperity Capital Management LLC, founded in 2018, serving as Chief Executive Officer.
Current jobs include President, Chief Executive Officer & Director at Adial Pharmaceuticals, Inc. since 2022; Independent External Director at Neurosense Therapeutics Ltd. since 2021; and Director at Virginia Biotechnology Association since 2022.
Former jobs include President, CEO & Head-Investor Relations at New Generation Biofuels Holdings, Inc. from 2010; President, Chief Executive Officer & Director at New Generation Biofuels, Inc.; Director-Operations Analysis at General Electric Capital Corp.; Director at The Medicalert Foundation from 2013 to 2016; Independent Director at LadRx Corp.
from 2022 to 2025; Chief Financial Officer & Director at Indivior Ltd. from 2014 to 2017; Vice President-Financial Planning & Analysis at The Home Depot, Inc. from 2000 to 2001; Vice President-Financial Planning & Analysis at MCI, Inc. from 1997 to 2000; Chief Financial Officer & Secretary at Osiris Therapeutics, Inc. from 2004 to 2007; Vice President-Financial Planning & Analysis at Constellation Energy Group, Inc. from 2001 to 2004; Chief Financial Officer at Sucampo Pharmaceuticals LLC from 2011 to 2014; Chief Financial Officer at Reckitt Benckiser Pharmaceuticals, Inc.; Chief Financial Officer & Senior Vice President at GE Capital Business Processes Management Services Ltd. from 1982 to 1997; and Vice President-Financial Planning & Analysis at Manufacturers Components, Inc. from 1997 to 2020.
Education includes undergraduate studies at Rutgers State University of New Jersey and an MBA from Villanova University.